Background. A lot of the therapeutic proposals for COVID-19 are actually associated with adverse consequences, such as the danger of QT interval prolongation and torsades de pointes (TdP). The target was to determine the usage of medication which has a threat of QT interval prolongation in 21 clinics/hospitals in https://directivepublications.org/journal-of-vascular-medicine/